News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Daily News Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines L.A. McKeown December 28, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Daily News ESC Releases Guidance on How to Address CVD in COVID-19 Era Yael L. Maxwell November 17, 2021
News Conference News AHA 2021 No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis Michael O'Riordan November 15, 2021
News Conference News TCT 2021 Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On Caitlin E. Cox November 09, 2021
News Daily News Good TAVI Outcomes in Young Patients, but Population Is Unique Michael O'Riordan October 22, 2021
News Conference News EACTS 2021 TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb Shelley Wood October 20, 2021
News Daily News USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention Shelley Wood October 15, 2021
News Daily News FDA Issues New Guidance on Sodium Targets for Food Industry L.A. McKeown October 14, 2021
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Daily News Diabetes Progression in Statin-Treated Patients: VA Data Michael O'Riordan October 06, 2021
News Daily News Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT Michael O'Riordan October 04, 2021
News Daily News Women Stand to Gain the Most From Standardized STEMI Protocols Michael O'Riordan September 30, 2021
News Daily News Cumulative Burden of LDL Cholesterol Increases CHD Risk Michael O'Riordan September 23, 2021
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Daily News Heterozygous FH Diagnosed Late, Remains Undertreated Michael O'Riordan September 13, 2021
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021